Connect with us

News

InvestorBrandNetwork Announces C3 Chat Show Podcast with CNS Pharmaceuticals Inc. Chairman and CEO John Climaco

gbafNews28

LOS ANGELES, Jan. 13, 2021 — via InvestorWireInvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities, today announces that John Climaco, Chairman and CEO of CNS Pharmaceuticals Inc. (NASDAQ: CNSP), was recently interviewed on the C3 Chat Show Podcast, a series that addresses topics related to entrepreneurship, life experiences and best practices from experts.

The podcast, co-hosted by Sid Vaidya and Eric Gershey, is available for on-demand listening at https://anchor.fm/c3chat.

During the interview, Climaco provided an overview of CNS Pharmaceuticals and recent FDA approval to begin clinical trials on the company’s lead drug candidate, Berubicin, a proposed treatment for glioblastoma multiforme (GBM), an aggressive form of brain cancer currently considered incurable.

“This is the biggest news we’ve announced since our IPO back in November 2019. The FDA approved an Investigational New Drug application, which allows us to proceed with our clinical trial. Based on that IND approval, we expect, in the next 90 to 120 days, we will go from zero active clinical trials today to three active clinical trials for our lead compound, Berubicin, which is a novel treatment for glioblastoma, the most common and aggressive form of primary brain cancer,” Climaco said.

“We have five employees at this company, so we are a tiny little shop,” he continued. “But we have an absolute powerhouse compound. We pushed that through and got the FDA to greenlight a clinical trial, which is really monumental. The Food and Drug Administration of the United States said it’s safe to proceed and investigate this drug in humans.”

“It’s a big day for GBM patients. This is a population that has not seen hardly any innovation for 15 years,” he said. “If you get GBM, the sad reality is you’re probably going to die from it. We think we can change that game.”

“We expect to be enrolling patients as soon as January or February. We know how this drug behaves. It was the subject of a very successful Phase I trial where 44 percent of patients had their disease stabilized or they started to get better. Those are remarkable statistics, because GBM is the deadliest form of brain cancer. Basically no one gets better. But we have a patient who is still alive 14 years after treatment, and that’s just incredible because the median survival for GBM patients following diagnosis is 14-16 months.”

Throughout the podcast, Climaco discussed the difficulties in treating brain cancers because of the brain’s protective covering of specialized cells that shield it from outside infection. He also explained how Berubicin is able to cross the blood-brain barrier and attack tumor cells inside the brain.

Learn more by listening to the full interview at https://anchor.fm/c3chat.

About CNS Pharmaceuticals Inc.

CNS Pharmaceuticals is developing novel treatments for primary and metastatic cancers of the brain and central nervous system. Its lead drug candidate, Berubicin, is proposed for the treatment of glioblastoma multiforme (GBM), an aggressive and incurable form of brain cancer. CNS holds a worldwide exclusive license to the Berubicin chemical compound and has acquired all data and know-how from Reata Pharmaceuticals Inc. related to a completed Phase 1 clinical trial with Berubicin in malignant brain tumors, which Reata conducted in 2006. In this trial the overall response rate of stable disease or better was 44%. This 44% disease control rate was based on 11 patients (out of 25 evaluable patients) with stable disease, plus responders. One patient experienced a durable complete response and remains cancer-free as of February 20, 2020. These Phase 1 results represent a limited patient sample size and, while promising, are not a guarantee that similar results will be achieved in subsequent trials. Its second drug candidate, WP1244, is a novel DNA binding agent that has shown in preclinical studies that it is 500 times more potent than the chemotherapeutic agent daunorubicin in inhibiting tumor cell proliferation.

For more information, visit: www.cnspharma.com

About InvestorBrandNetwork

The InvestorBrandNetwork (“IBN”) consists of financial brands introduced to the investment public over the course of 15+ years. With IBN, we have amassed a collective audience of millions of social media followers. These distinctive investor brands aim to fulfill the unique needs of a growing base of client-partners. IBN will continue to expand our branded network of highly influential properties, leveraging the knowledge and energy of specialized teams of experts to serve our increasingly diversified list of clients.

Through NetworkNewsWire (“NNW”) and its affiliate brands, IBN provides: (1) access to a network of wire solutions via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions to ensure maximum impact; (4) full-scale distribution to a growing social media audience; (5) a full array of corporate communications solutions; and (6) a total news coverage solution.

For more information on IBN, visit https://www.InvestorBrandNetwork.com.

Please see full terms of use and disclaimers on the InvestorBrandNetwork website, applicable to all content provided by IBN wherever published or re-published: https://IBN.fm/Disclaimer

Forward-Looking Statements

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company’s SEC filings. These risks and uncertainties could cause the company’s actual results to differ materially from those indicated in the forward-looking statements.

Corporate Communications

InvestorBrandNetwork (IBN) Los Angeles, California www.InvestorBrandNetwork.com 310.299.1717 Office [email protected]

Primary Logo

News

Celanese Announces Engineered Materials Price Increases

gbafNews28

Celanese Corporation (NYSE: CE), a global chemical and specialty materials company, today announced price increases on its portfolio of engineered materials in response to strengthening demand for its products and increased transportation, energy and raw material prices. The price increases below will be effective for orders shipped on or after February 1, 2021, or as contracts otherwise allow.

Product

Global

GUR

$0.25 kg

PA 66

$0.30 kg

PA 6

$0.20 kg

PBT

$0.20 kg

Technical TPE

$0.15 kg

PP, LFT & Amorphous

$0.30 kg

POM

$0.20 kg

Individual grades may be subject to higher increases than specified above.

Celanese is a leading supplier of engineered materials and the only supplier with global production facilities providing local supply to all regions of the world. Celanese continues to support its customers globally with a growing specialty portfolio of engineering polymers and functionalized grades. The company is committed to enhancing its specialty product offerings and capabilities through ongoing investments in compounding assets, technologies, and product and application expertise.

Customers should contact their Celanese account manager for more information.

About Celanese

Celanese Corporation is a global chemical leader in the production of differentiated chemistry solutions and specialty materials used in most major industries and consumer applications. Our businesses use the full breadth of Celanese’s global chemistry, technology and commercial expertise to create value for our customers, employees, shareholders and the corporation. As we partner with our customers to solve their most critical business needs, we strive to make a positive impact on our communities and the world through The Celanese Foundation. Based in Dallas, Celanese employs approximately 7,700 employees worldwide and had 2019 net sales of $6.3 billion. For more information about Celanese Corporation and its product offerings, visit www.celanese.com or our blog at www.celaneseblog.com.

Celanese Contacts:

Investor Relations

Brandon Ayache

+1 972 443 8509

[email protected]

Media Relations – Global

W. Travis Jacobsen

+1 972 443 3750

[email protected]

Media Relations Europe (Germany)

Petra Czugler

+49 69 45009 1206

[email protected]

Continue Reading

News

American Campus Communities Announces Quarterly Dividend

gbafNews28

American Campus Communities, Inc. (NYSE: ACC), the nations largest owner and manager of high-quality student housing properties in the U.S., announced that on January 18, 2021 its Board of Directors declared a regular quarterly dividend of $0.47 per share of common stock, payable on February 19, 2021, to shareholders of record at the close of business on January 28, 2021.

About American Campus Communities

American Campus Communities, Inc. is the largest owner, manager and developer of high-quality student housing communities in the United States. The company is a fully integrated, self-managed and self-administered equity real estate investment trust (REIT) with expertise in the design, finance, development, construction management and operational management of student housing properties. As of September 30, 2020, American Campus Communities owned 166 student housing properties containing approximately 111,900 beds. Including its owned and third-party managed properties, ACC’s total managed portfolio consisted of 204 properties with approximately 139,900 beds. Visit www.americancampus.com.

Forward-Looking Statements

In addition to historical information, this press release contains forward-looking statements under the applicable federal securities law. These statements are based on managements current expectations and assumptions regarding markets in which American Campus Communities, Inc. (the Company) operates, operational strategies, anticipated events and trends, the economy, and other future conditions. Forward-looking statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. These risks and uncertainties that could cause actual results to differ materially from those expressed or implied in the forward looking-statements include those related to the COVID-19 pandemic, about which there are still many unknowns, including the duration of the pandemic and the extent of its impact, and those discussed in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K for the year ended December 31, 2019 under the heading Risk Factors and under the heading Business – Forward-looking Statements and subsequent quarterly reports on Form 10-Q. We undertake no obligation to publicly update any forward-looking statements, including our preleasing activity or expected full year 2020 operating results, whether as a result of new information, future events, or otherwise.

Ryan Dennison

Investor Relations

(512) 732-1000

Continue Reading

News

Amkor Technology to Announce Fourth Quarter and Full Year 2020 Financial Results on February 8, 2021

gbafNews28

Amkor Technology, Inc. (Nasdaq: AMKR), a leading provider of semiconductor packaging and test services, today announced that it will issue its financial results for the fourth quarter and full year 2020 after the close of trading on the NASDAQ Global Select Market on Monday, February 8, 2021. Amkor management will host a conference call to discuss the company’s financial results at 5:00 p.m. Eastern Time on Monday, February 8, 2021.

The conference call can be accessed at Amkor’s website: www.amkor.com. You may also access the call by dialing 1-877-407-4019 or 1-201-689-8337. A replay of the call will be made available at Amkor’s website or by dialing 1-877-660-6853 or 1-201-612-7415 (conference ID 13715048).

About Amkor Technology, Inc.

Amkor Technology, Inc. is one of the worlds largest providers of outsourced semiconductor packaging and test services. Founded in 1968, Amkor pioneered the outsourcing of IC packaging and test and is now a strategic manufacturing partner for the worlds leading semiconductor companies, foundries and electronics OEMs. Amkors operational base includes production facilities, product development centers, and sales and support offices located in key electronics manufacturing regions in Asia, Europe and the USA. For more information, visit www.amkor.com.

Vincent Keenan

Vice President, Investor Relations

480-786-7594

[email protected]

Continue Reading
Editorial & Advertiser disclosureOur website provides you with information, news, press releases, Opinion and advertorials on various financial products and services. This is not to be considered as financial advice and should be considered only for information purposes. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third party websites, affiliate sales networks, and may link to our advertising partners websites. Though we are tied up with various advertising and affiliate networks, this does not affect our analysis or opinion. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you, or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish sponsored articles or links, you may consider all articles or links hosted on our site as a partner endorsed link.

Call for Entries

Global Banking and Finance Review Awards Nominations 2021
2021 Awards now open. Click Here to Nominate

Latest Posts

gbafNews28 gbafNews28
News36 mins ago

Celanese Announces Engineered Materials Price Increases

Celanese Corporation (NYSE: CE), a global chemical and specialty materials company, today announced price increases on its portfolio of engineered...

gbafNews28 gbafNews28
News49 mins ago

American Campus Communities Announces Quarterly Dividend

American Campus Communities, Inc. (NYSE: ACC), the nations largest owner and manager of high-quality student housing properties in the U.S.,...

gbafNews28 gbafNews28
News1 hour ago

Amkor Technology to Announce Fourth Quarter and Full Year 2020 Financial Results on February 8, 2021

Amkor Technology, Inc. (Nasdaq: AMKR), a leading provider of semiconductor packaging and test services, today announced that it will issue...

gbafNews28 gbafNews28
News1 hour ago

Alera Group Acquires CSNW Benefits

DEERFIELD, Ill. and PORTLAND, Ore., Jan. 18, 2021 /PRNewswire-PRWeb/ — Alera Group, a leading national insurance and financial services firm, today...

gbafNews28 gbafNews28
News1 hour ago

Summit Hotel Properties Announces Fourth Quarter And Full Year 2020 Earnings Release Date

AUSTIN, Texas, Jan. 18, 2021 /PRNewswire/ — Summit Hotel Properties, Inc. (NYSE: INN) (the “Company”) today announced that it will...

gbafNews28 gbafNews28
News1 hour ago

Planswell Fills C-Suite with Eye Towards Global Expansion

Early US success ignites drive to Latin America, Asia     TORONTO, Jan. 18, 2021 /PRNewswire/ – Planswell,  the Toronto-based startup...

gbafNews28 gbafNews28
News1 hour ago

Hawaiian Electric Industries To Announce Fourth Quarter And Full Year 2020 Results And 2021 Earnings Guidance Feb. 16; American Savings Bank To Announce 2020 Results Jan. 29

HONOLULU, Jan. 18, 2021 /PRNewswire/ — Hawaiian Electric Industries, Inc. (HEI) (NYSE: HE) will announce its fourth quarter and full...

gbafNews28 gbafNews28
News1 hour ago

Transom Consulting Group Announces the Promotion of Paul Yoo to Partner

LOS ANGELES, Jan. 18, 2021 /PRNewswire/ — Transom Consulting Group, a leading strategy and operational excellence consultancy and investment bank, announced...

gbafNews28 gbafNews28
News2 hours ago

Granite REIT Declares Distribution for January 2021

Granite Real Estate Investment Trust (Granite) (TSX: GRT.UN / NYSE: GRP.U) announced today that its board of trustees has declared...

gbafNews28 gbafNews28
News2 hours ago

Suncity Group Announces 2021 Outlook

Striding Towards a Bright Future   MACAU – Media OutReach – 5 January 2021 – Under the impact of the COVID-19 pandemic, 2020...